Jiang Guoqing, Bai Dousheng, Chen Ping, Qian Jianjun, Jin Shengjie
1 Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu Province, China.
Surg Innov. 2018 Jun;25(3):218-223. doi: 10.1177/1553350618759151. Epub 2018 Mar 13.
Liver resection was not formerly recommended in patients with both hepatocellular carcinoma (HCC) and portal hypertension because of difficult perioperative bleeding control and postoperative liver failure. Splenectomy is a proven method with which to overcome these problems. To investigate the safety and feasibility of synchronous laparoscopic splenectomy and azygoportal disconnection with hepatectomy (LSDH) for treatment of portal hypertension accompanied with HCC, we describe a clinical cohort of 10 patients who underwent a new technique of synchronous LSDH.
A cohort of 10 cirrhotic patients with HCC, esophageal/gastric variceal bleeding, and hypersplenism received LSDH. A 6-port method was used for LSDH. This procedure comprises 5 steps: laparoscopic splenectomy, intraoperative splenic blood salvage, laparoscopic azygoportal disconnection, laparoscopic partial hepatectomy, and removal of spleen and liver specimens. Intraoperative autologous cell salvage was performed before hepatectomy.
LSDH was successful in all patients. There was no conversion to open operations. The operative time was 220.5 ± 19.8 minutes, blood loss was 264.0 ± 160.3 mL, and postoperative hospital stay was 10.2 ± 1.8 days.
Selective synchronous LSDH is a feasible, effective, and safe surgical procedure with satisfactory short-term efficacy. It is a promising minimally invasive treatment option for patients with cirrhotic HCC and portal hypertension.
由于围手术期出血难以控制以及术后肝衰竭,以往不建议对同时患有肝细胞癌(HCC)和门静脉高压的患者进行肝切除术。脾切除术是一种已被证实可克服这些问题的方法。为了研究同步腹腔镜脾切除术联合奇静脉门静脉断流术与肝切除术(LSDH)治疗伴有HCC的门静脉高压的安全性和可行性,我们描述了一组接受同步LSDH新技术的10例患者的临床队列。
一组10例患有HCC、食管/胃静脉曲张出血和脾功能亢进的肝硬化患者接受了LSDH。采用6孔法进行LSDH。该手术包括5个步骤:腹腔镜脾切除术、术中脾血回收、腹腔镜奇静脉门静脉断流术、腹腔镜肝部分切除术以及切除脾脏和肝脏标本。在肝切除术前进行术中自体血回收。
所有患者LSDH均成功。无中转开腹手术。手术时间为220.5±19.8分钟,失血量为264.0±160.3毫升,术后住院时间为10.2±1.8天。
选择性同步LSDH是一种可行、有效且安全的手术方法,短期疗效满意。对于肝硬化HCC和门静脉高压患者,它是一种有前景的微创治疗选择。